SOW
DNLI icon

State of Wyoming’s Denali Therapeutics DNLI Stock Holding History

State of Wyoming’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Buy
+17,778
New +$365K 0.05% 447
2026
Q1 		– Sell
-2,686
Closed -$44.3K – 1857
2025
Q4 		$44.3K Buy
2,686
+532
+25% +$8.98K ﹤0.01% 1576
2025
Q3 		$31.3K Buy
2,154
+55
+3% +$790 ﹤0.01% 1657
2025
Q2 		$29.4K Buy
+2,099
New +$29.5K ﹤0.01% 1665
2022
Q3 		– Sell
-8
Closed – – 1626
2022
Q2 		$0 Sell
8
-1,126
-99% -$29.5K ﹤0.01% 1935
2022
Q1 		$36K Buy
1,134
+748
+194% +$25.7K 0.02% 1225
2021
Q4 		$18K Buy
386
+316
+451% +$15K 0.01% 1496
2021
Q3 		$4K Sell
70
-267
-79% -$15K ﹤0.01% 1109
2021
Q2 		$26K Buy
337
+60
+22% +$3.71K 0.02% 879
2021
Q1 		$16K Buy
+277
New +$18.5K 0.03% 342

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wyoming's DNLI Position: Q2 2026 in Review

State of Wyoming opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 17,778 shares worth $457K. The stake represents 0.05% of the portfolio and ranks #447 among its holdings. This is a return to the name: State of Wyoming previously reported a position in DNLI as recently as Q4 2025.

State of Wyoming first reported a position in DNLI in Q1 2021 and has held it in 10 quarters since. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • State of Wyoming held 17,778 shares of Denali Therapeutics worth $457K as of Q2 2026.
  • Denali Therapeutics was a new State of Wyoming position in Q2 2026.
  • Denali Therapeutics made up 0.05% of State of Wyoming's portfolio in Q2 2026, its #447 holding.
  • State of Wyoming first reported a position in Denali Therapeutics in Q1 2021 and has held it in 10 quarters since.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.